E-LIB Suche - Ergebnisse für: Zernig, G.

1

Therapeutic reference range for duloxetine in the treatment..:

Amann, F. ; Kochtyrew, M. ; Zernig, G...
Neuroscience Applied. 3 (2024) - p. 104077 , 2024

Link: https://doi.org/10.1016/..

2

P.0693 Escitalopram: Drug monitoring for dose titration? Sy..:

Eichentopf, L. ; Hiemke, C. ; Hefner, G....
European Neuropsychopharmacology. 53 (2021) - p. S507-S508 , 2021

Link: https://doi.org/10.1016/..

3

Measuring Adherence to Medication in Schizophrenia: The Rel..:

Yalcin-Siedentopf, N. ; Wartelsteiner, F. ; Kaufmann, A....
International Journal of Neuropsychopharmacology. 18 (2014) 5 - p. pyu091-pyu091 , 2014

Link: https://doi.org/10.1093/..

4

Therapeutisches Drug-Monitoring in der Psychiatrie: Kurze Z..:

für die TDM-Gruppe der AGNP ; Gründer, G. ; Baumann, P....
Der Nervenarzt. 85 (2013) 7 - p. 847-855 , 2013

Link: https://doi.org/10.1007/..

5

Einsatz von Bupropion bei älteren Patienten: Ist langfristi..:

Hausmann, Armand ; Bösch, A. ; Fuchs, M...
Psychopraxis. 14 (2011) 2 - p. 23-25 , 2011

Link: https://doi.org/10.1007/..

6

P.2.c.013 Two generic antidepressant medications and their ..:

Chenu, F. ; Batten, L. ; Zernig, G....
European Neuropsychopharmacology. 19 (2009) - p. S411 , 2009

Link: https://doi.org/10.1016/..

7

Olanzapine and breast-feeding: changes of plasma concentrat..:

Whitworth, A. ; Stuppaeck, C. ; Yazdi, K....
Journal of Psychopharmacology. 24 (2008) 1 - p. 121-123 , 2008

Link: https://doi.org/10.1177/..

8

The influence of age on plasma levels of risperidone and 9-..:

Aichhorn, W. ; Marksteiner, J. ; Weiss, U....
European Neuropsychopharmacology. 12 (2002) - p. 271-272 , 2002

Link: https://doi.org/10.1016/..

9

MDMA ('ecstasy') enhances basal acetylcholine release in br..:

Fischer, H. S. ; Zernig, G. ; Schatz, D. S...
European Journal of Neuroscience. 12 (2000) 4 - p. 1385-1390 , 2000

Link: https://doi.org/10.1046/..

10

In vivo estimates of efficacy at 5-HT 1A receptors: effects..:

Koek, W. ; Assié, M.-B. ; Zernig, G..
Psychopharmacology. 149 (2000) 4 - p. 377-387 , 2000

Link: https://doi.org/10.1007/..

11

CALCULATION OF AFFINITY AND EFFICACY WITH THE METHOD OF PAR..:

Zernig, G.
Behavioural Pharmacology. 9 (1998) 1 - p. S97 , 1998

Link: https://doi.org/10.1097/..

12

CALCULATION OF AFFINITY AND EFFICACY WITH THE METHOD OF PAR..:

Zernig, G.
Behavioural Pharmacology. 9 (1998) Supplement - p. S97 , 1998

Link: https://doi.org/10.1097/..

13

Acute and prolonged effects of clocinnamox and methoclocinn..:

Zernig, G. ; Fibiger, H. C.
Psychopharmacology. 135 (1998) 1 - p. 17-21 , 1998

Link: https://doi.org/10.1007/..

14

In vivo apparent affinity and efficacy estimates for ? opia..:

Zernig, G. ; Young, Alice M. ; Walker, E. A.
Psychopharmacology. 136 (1998) 1 - p. 15-23 , 1998

Link: https://doi.org/10.1007/..

15

Clocinnamox inhibits the intravenous self-administration of..:

Zernig, G. ; Lewis, J. W. ; Woods, J. H.
Psychopharmacology. 129 (1997) 3 - p. 233-242 , 1997

Link: https://doi.org/10.1007/..